Drug Efflux and parC Mutations Are Involved in Fluoroquinolone Resistance in Viridans Group Streptococci
- 1 October 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (10) , 2520-2523
Abstract
Nine ciprofloxacin-resistant viridans group streptococci isolated from asymptomatic carriers were analyzed. Identification to the species level by using three different commercial systems and a PCR-based approach was inconsistent. The nucleotide sequences of fragments of the parC , parE , gyrA , and gyrB genes showed considerable intra- and interspecies variations, and these variations mainly involved silent mutations. Three isolates had changes in Ser-79 of ParC (to Phe or Tyr). Phenotypic characterization indicated that eight of the nine isolates had a putative efflux mechanism that would confer low-level resistance to ciprofloxacin.Keywords
This publication has 28 references indexed in Scilit:
- Whole-cell protein electrophoretic analysis of viridans streptococci: evidence for heterogeneity among Streptococcus mitis biovarsInternational Journal of Systematic and Evolutionary Microbiology, 1998
- Bacteremia Due to Viridans Streptococci That Are Highly Resistant to Penicillin: Increase Among Neutropenic Patients with CancerClinical Infectious Diseases, 1995
- Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk FactorsClinical Infectious Diseases, 1994
- Identity of viridans streptococci isolated from cases of infective endocarditisJournal of Medical Microbiology, 1993
- Efflux-mediated fluoroquinolone resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1993
- Streptococcal and Enterococcal Bacteremia in Patients with CancerClinical Infectious Diseases, 1992
- Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing FactorsClinical Infectious Diseases, 1992
- The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA proteinAntimicrobial Agents and Chemotherapy, 1992
- Viridans Streptococcal Endocarditis: Clinical, Microbiological, and Echocardiographic CorrelationsThe Journal of Infectious Diseases, 1986
- Viridans Streptococcal Endocarditis: The Role of Various Species, Including Pyridoxal-Dependent StreptococciClinical Infectious Diseases, 1979